Filter announcements
Loading...
Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services
TAKE Limited delivered strong Q1 FY27 results: consolidated revenue hit ₹30.37 Cr and net profit reached ₹1.06 Cr, reversing prior-year losses. The company is strategically expanding into Biohacking, Nutraceuticals, and Digital Longevity Solutions, targeting high-margin, recurring revenue.
Take Solutions Limited is changing its name to TAKE Limited. The new name becomes effective August 12, 2026, with the stock symbol 'TAKE' remaining unchanged.
TAKE Solutions Limited officially changed its name to TAKE Limited after receiving the Certificate of Incorporation. This marks a significant corporate development.
TAKE Solutions reported a significant turnaround to a ₹2.72 Cr standalone net profit for FY26 from a ₹69.74 Cr loss last year. Consolidated net profit hit ₹10.85 Cr with ₹54.19 Cr revenue, indicating business resumption. Auditors issued a qualified opinion on tax asset recoverability (₹12.92 Cr consolidated).
Take Solutions is entering India's growing longevity and anti-ageing market, developing science-backed nutraceuticals, biohacking, and digital preventive healthcare solutions. This leverages their expertise to tap into a significant market opportunity.